Cargando…

Amplification and overexpression of the EGF receptor and c-erbB-2 proto-oncogenes in human stomach cancer.

Detalles Bibliográficos
Autores principales:	Lemoine, N. R., Jain, S., Silvestre, F., Lopes, C., Hughes, C. M., McLelland, E., Gullick, W. J., Filipe, M. I.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1991
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977330/ https://www.ncbi.nlm.nih.gov/pubmed/1677259

Ejemplares similares

The interactome of human EGF/ErbB receptors
por: Uetz, Peter, et al.
Publicado: (2006)

Amplification of c-erbB-2 proto-oncogene in cancer foci, adjacent normal, metastatic and normal tissues of human primary gastric adenocarcinomas.
por: Kim, J. S., et al.
Publicado: (1997)

erbB-2 antisense oligonucleotides inhibit the proliferation of breast carcinoma cells with erbB-2 oncogene amplification.
por: Colomer, R., et al.
Publicado: (1994)

Absence of Activating Mutations in the Transmembrane Domain of the c‐erbB‐2 Proto‐oncogene in Human Lung Cancer
por: Sachse, Richard, et al.
Publicado: (1992)

Proto-oncogene c-erbB2 initiates rat primordial follicle growth via PKC and MAPK pathways
por: Li-Ping, Zheng, et al.
Publicado: (2010)

Clozapine-dependent inhibition of EGF/neuregulin receptor (ErbB) kinases
por: Kobayashi, Yutaro, et al.
Publicado: (2019)

Expression of oncogenes in thyroid tumours: coexpression of c-erbB2/neu and c-erbB.
por: Aasland, R., et al.
Publicado: (1988)

FAK signaling is critical for ErbB-2/ErbB-3 receptor cooperation for oncogenic transformation and invasion
por: Benlimame, Naciba, et al.
Publicado: (2005)

A monoclonal antibody targeting ErbB2 domain III inhibits ErbB2 signaling and suppresses the growth of ErbB2-overexpressing breast tumors
por: Meng, Y, et al.
Publicado: (2016)

Quantitative Analysis of ErbB1 and ErbB2 Genes Amplification by a High Performance Liquid Chromatography
por: Rasti, Mozhgan, et al.
Publicado: (2014)

ErbB2/HER2/Neu resembles an autoinhibited invertebrate EGF receptor
por: Alvarado, Diego, et al.
Publicado: (2009)

Effects of ErbB2 Overexpression on the Proteome and ErbB Ligand-specific Phosphosignaling in Mammary Luminal Epithelial Cells
por: Worthington, Jenny, et al.
Publicado: (2017)

c-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes.
por: Gullick, W. J., et al.
Publicado: (1991)

Pattern of expression of c-erbB-2 oncoprotein in human fetuses.
por: Quirke, P., et al.
Publicado: (1989)

c-erbB-2 in astrocytomas: infrequent overexpression by immunohistochemistry and absence of gene amplification by fluorescence in situ hybridization.
por: Haapasalo, H., et al.
Publicado: (1996)

DSE promotes aggressive glioma cell phenotypes by enhancing HB-EGF/ErbB signaling
por: Liao, Wen-Chieh, et al.
Publicado: (2018)

c-erbB-2 expression in benign and malignant breast disease.
por: Gusterson, B. A., et al.
Publicado: (1988)

C-erbB2 mRNA expression in human breast tumours: comparison with c-erbB2 DNA amplification and correlation with prognosis.
por: Parkes, H. C., et al.
Publicado: (1990)

Co‐amplification of c‐myc and c‐erbB‐2 Oncogenes in a Poorly Differentiated Human Gastric Cancer
por: Tsuchiya, Terumasa, et al.
Publicado: (1989)

Critical determination of the frequency of c-erbB-2 amplification in breast cancer.
por: Hubbard, A. L., et al.
Publicado: (1994)

c-erbB-2 oncoprotein expression in primary and advanced breast cancer.
por: Lovekin, C., et al.
Publicado: (1991)

The mechanism of c-erbB-2 gene product increase in stomach cancer cell lines.
por: Bae, C. D., et al.
Publicado: (1993)

Modulation of ErbB2 Blockade in ErbB2-Positive Cancers: The Role of ErbB2 Mutations and PHLDA1
por: Li, Guangyuan, et al.
Publicado: (2014)

An immunohistochemical evaluation of c-erbB-2 expression in human breast carcinoma.
por: Barnes, D. M., et al.
Publicado: (1988)

c-erbB-4 protein expression in human breast cancer
por: Kew, T Y, et al.
Publicado: (2000)

c-erbB-2 oncogene as a prognostic marker in breast cancer.
por: Perren, T. J.
Publicado: (1991)

Prognostic significance of the c-erbB-2 oncogene product in childhood medulloblastoma.
por: Gilbertson, R. J., et al.
Publicado: (1995)

ErbB Family Signalling: A Paradigm for Oncogene Addiction and Personalized Oncology
por: Jacobi, Nico, et al.
Publicado: (2017)

Mutation and genomic amplification of the PIK3CA proto-oncogene in pituitary adenomas
por: Murat, C.B., et al.
Publicado: (2012)

A upconversion luminescene biosensor based on dual-signal amplification for the detection of short DNA species of c-erbB-2 oncogene
por: Lan, Jianming, et al.
Publicado: (2016)

ErbB2 Dephosphorylation and Anti-Proliferative Effects of Neuregulin-1 in ErbB2-Overexpressing Cells; Re-evaluation of Their Low-Affinity Interaction
por: Wang, Ran, et al.
Publicado: (2013)

Buformin inhibits the stemness of erbB-2-overexpressing breast cancer cells and premalignant mammary tissues of MMTV-erbB-2 transgenic mice
por: Parris, Amanda B., et al.
Publicado: (2017)

Novel multi-targeted ErbB family inhibitor afatinib blocks EGF-induced signaling and induces apoptosis in neuroblastoma
por: Mao, Xinfang, et al.
Publicado: (2016)

A monoclonal antibody to the human c-erbB3 protein stimulates the anchorage-independent growth of breast cancer cell lines.
por: Rajkumar, T., et al.
Publicado: (1994)

Endocrine resistance in breast cancer: new roles for ErbB3 and ErbB4
por: Sutherland, Robert L
Publicado: (2011)

Mutational Screening in Tyrosine-Kinase Domain of erbB1 And erbB2 Genes
por: ALONSO, Juan Manuel Fernández
Publicado: (2005)

ErbB activation signatures as potential biomarkers for anti-ErbB3 treatment in HNSCC
por: Alvarado, Diego, et al.
Publicado: (2017)

Therapeutic targeting of erbB3 with MM-121/SAR256212 enhances antitumor activity of paclitaxel against erbB2-overexpressing breast cancer
por: Wang, Shuiliang, et al.
Publicado: (2013)

An In Silico Evaluation of Deleterious Nonsynonymous Single Nucleotide Polymorphisms in the ErbB3 Oncogene
por: Raghav, Dhwani, et al.
Publicado: (2013)

Gastric Cancer Cell Glycosylation as a Modulator of the ErbB2 Oncogenic Receptor
por: Duarte, Henrique O., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_pjhuohq6vr4lnqavoko2engbc9